Showing results (171-180 of 377) with videos related to

Sort By:
Pageof 38
Journal of Gastroenterology and Hepatology|October 26, 2005
Sclerotherapy for gastric fundal variceal bleeding: is complete obliteration possible without cyanoacrylate?Kuniyuki Kojima, Hiroo Imazu, Masahiko Matsumura, et al.
Molecular Medicine Reports|November 26, 2014
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis modelAkitoshi Douhara, Kei Moriya, Hitoshi Yoshiji, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 29, 2021
Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute-on-chronic liver failure development and prognosis in patients with liver cirrhosisMasahide Enomoto, Hiroaki Takaya, Tadashi Namisaki, et al.
World Journal of Gastroenterology|September 11, 2025
Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic ratsMasafumi Oyama, Kosuke Kaji, Norihisa Nishimura, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|December 14, 2023
Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitisMisako Tanaka, Kosuke Kaji, Norihisa Nishimura, et al.
Biomedicines|May 27, 2023
A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell ActivationJunya Suzuki, Kosuke Kaji, Norihisa Nishimura, et al.
Biology|February 25, 2023
The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver FailureHiroaki Takaya, Tadashi Namisaki, Masahide Enomoto, et al.
Journal of Clinical Medicine|February 10, 2021
Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion ChemotherapyKei Moriya, Tadashi Namisaki, Hiroaki Takaya, et al.
Oncology Reports|December 8, 2004
Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administrationShigeki Kuriyama, Hitoshi Yoshiji, Seiji Nakai, et al.
World Journal of Gastroenterology|August 2, 2024
Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver diseaseAritoshi Koizumi, Kosuke Kaji, Norihisa Nishimura, et al.
Pageof 38